Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee 37203, USA; email:
Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee 37203, USA; email:
Annu Rev Genomics Hum Genet. 2021 Aug 31;22:219-238. doi: 10.1146/annurev-genom-121120-125204. Epub 2021 May 26.
Recent advances in genomic technology and widespread adoption of electronic health records (EHRs) have accelerated the development of genomic medicine, bringing promising research findings from genome science into clinical practice. Genomic and phenomic data, accrued across large populations through biobanks linked to EHRs, have enabled the study of genetic variation at a phenome-wide scale. Through new quantitative techniques, pleiotropy can be explored with phenome-wide association studies, the occurrence of common complex diseases can be predicted using the cumulative influence of many genetic variants (polygenic risk scores), and undiagnosed Mendelian syndromes can be identified using EHR-based phenotypic signatures (phenotype risk scores). In this review, we trace the role of EHRs from the development of genome-wide analytic techniques to translational efforts to test these new interventions to the clinic. Throughout, we describe the challenges that remain when combining EHRs with genetics to improve clinical care.
近年来,基因组技术的进步和电子健康记录(EHR)的广泛采用加速了基因组医学的发展,将基因组科学的有前景的研究成果引入临床实践。通过与 EHR 相关联的生物库在大人群中积累的基因组和表型数据,使人们能够在表型全基因组范围内研究遗传变异。通过新的定量技术,可以通过表型全基因组关联研究来探索多效性,使用许多遗传变异(多基因风险评分)的累积影响来预测常见复杂疾病的发生,并使用基于 EHR 的表型特征(表型风险评分)来识别未诊断的孟德尔综合征。在这篇综述中,我们从全基因组分析技术的发展到测试这些新干预措施到临床的转化努力,追溯了 EHR 的作用。在整个过程中,我们描述了将 EHR 与遗传学相结合以改善临床护理时仍然存在的挑战。